TrialESMO open2022

Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer.

E Van Cutsem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.